EMERALD study bolsters darunavir, cobicistat, emtricitabine and tenofovir alafenamide fumarate Aug. 11, 2017
FDA grants priority review to NDA for bictegravir/emtricitabine/tenofovir alafenamide in HIV Aug. 11, 2017
The PS externalization pathway as a potential new target for the development of anti-HIV-1 therapies Aug. 7, 2017
RSS